MedTrace Logo

Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic

NCT04876274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 181

Last updated 2022-03-18

Study results available
· View outcomes & findings →

Summary

The current study was to develop a software "Line@" based health education program, providing video-based health information and communication between diabetes patients and health-care professionals. This study also evaluated its effectiveness on improving glycemic control, attitude towards diabetes, knowledge about diabetes and self-care for type 2 diabetes patients in Taiwan.

The followings were the hypotheses of the study:

1. Compared to the control group, intervention group receiving "Line" based video education has a greater improvement on glycosylated hemoglobin (A1C).
2. Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on attitude towards diabetes.
3. Compared to the control group, intervention group receiving "Line" based video education has a better understanding on diabetic knowledge.
4. Compared to the control group, intervention group receiving "Line" based video education has a greater positive effect on self-care activity.

Conditions

Interventions

BEHAVIORAL

TMU-LOVE

Patients in intervention group could attend diabetes-related health educational video through the TMU-LOVE platform. Researcher would also send 2-3 videos per week with care massage every 2 weeks to the patients.

Sponsors & Collaborators

  • Taipei Medical University WanFang Hospital

    collaborator OTHER

  • Taipei Medical University

    lead OTHER

Principal Investigators

  • Chen Hsiang-Yin, Pharm.D. · Professor and Associate Dean, College of Pharmacy, Taipei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-14
Primary Completion
2020-12-29
Completion
2020-12-29

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04876274 on ClinicalTrials.gov